Clinical Trial Update: Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of Everolimus on HIV persistence after kidney or liver transplant; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV, Kidney Transplant | Phase 4 | Status: COMPLETED | Results posted: 2019-11-19